Our New Name

The Irish Medicines Board (IMB) changed its name to the Health Products Regulatory Authority (HPRA) on 1 July 2014. Established in 1996, the IMB name served us well. However, over the course of our 18 years as the IMB our regulatory remit expanded to include other health products as well as a number of health related functions.

HPRA_Standard_Colour_rgb

The HPRA name now clearly reflects the wider scope of our work, functions and responsibilities across the health products sector. At the same time, it is intended to build on the IMB’s established reputation as a professional, progressive and science driven public sector organisation.

 

The HPRA has a role in regulating:

  • Human and veterinary medicines

  • Clinical trials

  • Medical devices

  • Controlled drugs

  • Blood and blood components

  • Tissues and cells

  • Cosmetic products

  • Protection of animals used for scientific purposes

  • Human organs intended for transplantation

 

While our name has changed, the mission of the HPRA remains the same: To protect and enhance public and animal health through the regulation of medicines, medical devices and other health products.We are committed to working on behalf of patients and the public by making sure that health products are as safe as possible and do what they are intended to do.

View our introduction video to learn more.



Our New Brand Identity

As a regulator and protector of public health, our stakeholders must have confidence in our decision-making and our ability to deliver across our broad range of functions. A positive and clearly understood brand identity is central to this confidence.

Learn more about the HPRA's brand identity

‚Äč